Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad) Free BMY Stock Alerts

Bristol Myers Squibb (BMY) Short Interest Ratio & Short Volume

Bristol Myers Squibb logo
$44.25 +0.94 (+2.17%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$44.32 +0.08 (+0.17%)
As of 08/1/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Bristol Myers Squibb Short Interest Data

Bristol Myers Squibb (BMY) has a short interest of 38.38 million shares, representing 1.89% of the float (the number of shares available for trading by the public). This marks a -2.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 12.69 million shares to cover all short positions.

Current Short Interest
38,380,000 shares
Previous Short Interest
39,450,000 shares
Change Vs. Previous Month
-2.71%
Dollar Volume Sold Short
$1.78 billion
Short Interest Ratio
2.6 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
2,035,080,000 shares
Float Size
2,030,000,000 shares
Short Percent of Float
1.89%
Today's Trading Volume
18,626,740 shares
Average Trading Volume
12,693,902 shares
Today's Volume Vs. Average
147%
Short Selling Bristol Myers Squibb?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bristol Myers Squibb and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BMY Short Interest Over Time

BMY Days to Cover Over Time

BMY Percentage of Float Shorted Over Time

Bristol Myers Squibb Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202538,380,000 shares $1.78 billion -2.7%1.9%2.6 $46.47
6/30/202539,450,000 shares $1.83 billion +17.4%1.9%2.6 $46.35
6/15/202533,610,000 shares $1.67 billion +3.3%1.7%2.3 $49.71
5/31/202532,540,000 shares $1.57 billion -12.1%1.6%2.2 $48.26
5/15/202537,010,000 shares $1.69 billion -0.3%1.8%2.5 $45.72
4/30/202537,120,000 shares $1.86 billion +23.6%1.8%2.6 $50.21
4/15/202530,030,000 shares $1.50 billion +2.1%1.5%2.3 $49.98
3/31/202529,400,000 shares $1.79 billion -20.6%1.5%2.4 $61.05
3/15/202537,010,000 shares $2.18 billion +21.1%1.8%3.1 $59.01
2/28/202530,570,000 shares $1.83 billion +19.5%1.5%2.6 $59.71
2/15/202525,590,000 shares $1.38 billion -4.2%1.3%2.4 $53.85
1/31/202526,700,000 shares $1.57 billion -3.0%1.3%2.4 $58.86
1/15/202527,520,000 shares $1.54 billion +10.4%1.4%2.5 $55.96
12/31/202424,930,000 shares $1.41 billion -9.9%1.2%2.4 $56.56
12/15/202427,660,000 shares $1.54 billion +8.1%1.4%2.4 $55.78
11/30/202425,600,000 shares $1.52 billion -0.7%1.3%2.3 $59.22
11/15/202425,770,000 shares $1.45 billion +10.0%1.3%2.3 $56.22
10/31/202423,420,000 shares $1.31 billion +4.1%1.2%2.1 $55.74
10/15/202422,500,000 shares $1.19 billion +12.3%1.1%1.9 $52.76
9/30/202420,030,000 shares $1.04 billion -8.1%1.0%1.5 $51.74
9/15/202421,790,000 shares $1.07 billion -2.1%1.1%1.6 $49.13
8/31/202422,260,000 shares $1.11 billion -20.5%1.1%1.5 $49.95
8/15/202428,010,000 shares $1.38 billion +6.0%1.4%1.8 $49.12
7/31/202426,420,000 shares $1.26 billion -17.6%1.3%1.6 $47.56
7/15/202432,060,000 shares $1.29 billion +1.4%1.6%2 $40.15
6/30/202431,620,000 shares $1.31 billion +4.4%1.6%2.1 $41.53
6/15/202430,290,000 shares $1.25 billion +5.4%1.5%2.1 $41.20
5/31/202428,730,000 shares $1.18 billion +1.6%1.4%1.8 $41.13
5/15/202428,270,000 shares $1.26 billion +0.9%1.4%1.8 $44.55
4/30/202428,020,000 shares $1.23 billion -18.5%1.4%1.8 $43.96
4/15/202434,360,000 shares $1.67 billion -2.2%1.7%2.2 $48.51
3/31/202435,120,000 shares $1.90 billion -5.7%1.7%2.2 $54.23
3/15/202437,250,000 shares $1.96 billion +14.1%1.8%2.2 $52.49
2/29/202432,650,000 shares $1.66 billion +3.7%1.6%2.1 $50.73
2/15/202431,490,000 shares $1.56 billion +1.3%1.6%2.1 $49.45
1/31/202431,090,000 shares $1.52 billion +6.5%1.5%2 $48.87
1/15/202429,190,000 shares $1.47 billion +30.8%1.4%1.9 $50.31
12/31/202322,310,000 shares $1.14 billion -7.4%1.1%1.5 $51.31
12/15/202324,100,000 shares $1.23 billion -11.3%1.2%1.7 $50.84
11/30/202327,170,000 shares $1.34 billion +1.4%1.3%2 $49.38
Alien rocks potentially worth trillions… (Ad)

It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 trillion. These rare elements can’t be found on land… only in one high-pressure zone so extreme it could crush a human instantly. Inside? Materials essential to AI, quantum computing, and advanced weapons tech. That’s why global superpowers are in a race to secure them—and why Trump just signed an Executive Order pushing for immediate extraction.

Get the name and ticker of the $7 stock leading America’s supply race.
11/15/202326,800,000 shares $1.38 billion +14.5%1.3%2.1 $51.60
10/31/202323,400,000 shares $1.21 billion -12.5%1.2%1.9 $51.53
10/15/202326,750,000 shares $1.51 billion -15.3%1.3%2.4 $56.47
9/30/202331,590,000 shares $1.83 billion -14.6%1.5%2.9 $58.04
9/15/202336,980,000 shares $2.18 billion -15.5%1.8%3.5 $59.00
8/31/202343,760,000 shares $2.70 billion -18.2%2.1%4.4 $61.65
8/15/202353,510,000 shares $3.30 billion +221.6%2.6%5.6 $61.75
7/31/202316,640,000 shares $1.04 billion -8.6%0.8%1.9 $62.20
7/15/202318,210,000 shares $1.13 billion +1.2%0.9%2.2 $61.94
6/30/202318,000,000 shares $1.15 billion -1.9%0.9%2.2 $63.94
6/15/202318,340,000 shares $1.19 billion -2.7%0.9%2.3 $64.68
5/31/202318,840,000 shares $1.21 billion -12.3%0.9%2.3 $64.44
5/15/202321,490,000 shares $1.46 billion +13.6%1.0%2.7 $68.17
4/30/202318,920,000 shares $1.26 billion +5.8%0.9%2.4 $66.77
4/15/202317,880,000 shares $1.26 billion +3.5%0.9%2.3 $70.45
3/31/202317,270,000 shares $1.20 billion -17.0%0.8%2.1 $69.31
3/15/202320,810,000 shares $1.40 billion +22.3%1.0%2.5 $67.48
2/28/202317,020,000 shares $1.17 billion -4.0%0.8%2.1 $68.96
2/15/202317,720,000 shares $1.27 billion -14.5%0.9%2.1 $71.47
1/31/202320,720,000 shares $1.51 billion -1.2%1.0%2.3 $72.65
1/15/202320,960,000 shares $1.52 billion +14.9%1.0%2.3 $72.51
12/30/202218,250,000 shares $1.31 billion -26.7%0.9%2 $71.95
12/15/202224,880,000 shares $1.87 billion -1.4%1.2%2.6 $75.00
11/30/202225,220,000 shares $2.02 billion +3.5%1.2%2.6 $80.28
11/15/202224,360,000 shares $1.86 billion -1.7%1.2%2.5 $76.28
10/31/202224,770,000 shares $1.92 billion +7.3%1.2%2.6 $77.47
10/15/202223,080,000 shares $1.63 billion -4.6%1.1%2.5 $70.62
9/30/202224,180,000 shares $1.72 billion +4.7%1.1%2.5 $71.09
9/15/202223,090,000 shares $1.66 billion +1.7%1.1%2.4 $71.78
8/31/202222,710,000 shares $1.53 billion -4.7%1.1%2.2 $67.41
8/15/202223,840,000 shares $1.78 billion -14.3%1.1%2.2 $74.53
7/31/202227,830,000 shares $2.05 billion +1.8%1.3%2.3 $73.78
7/15/202227,330,000 shares $2.07 billion -29.9%1.3%2 $75.65
6/30/202238,980,000 shares $3.00 billion +13.1%1.8%2.7 $77.00
6/15/202234,460,000 shares $2.52 billion +4.3%1.6%2.3 $73.02
5/31/202233,040,000 shares $2.49 billion +2.7%1.6%2.2 $75.45
5/15/202232,180,000 shares $2.44 billion -9.0%1.5%2.1 $75.80
4/30/202235,370,000 shares $2.66 billion -16.3%1.7%2.2 $75.27
4/15/202242,240,000 shares $3.27 billion -10.8%2.0%2.8 $77.51
3/31/202247,340,000 shares $3.46 billion -11.9%2.2%3.1 $73.03
3/15/202253,730,000 shares $3.75 billion -15.0%2.4%3.8 $69.75
2/28/202263,200,000 shares $4.34 billion -10.8%2.9%4.5 $68.67
2/15/202270,880,000 shares $4.80 billion +171.4%3.2%4.9 $67.77
1/31/202226,120,000 shares $1.69 billion +10.2%1.2%1.9 $64.89
1/15/202223,710,000 shares $1.54 billion +16.6%1.1%1.8 $64.93
12/31/202120,340,000 shares $1.27 billion -7.3%0.9%1.6 $62.35
12/15/202121,930,000 shares $1.33 billion -5.7%1.0%1.7 $60.61
11/30/202123,260,000 shares $1.25 billion +14.8%1.1%1.9 $53.63
11/15/202120,260,000 shares $1.21 billion -9.6%0.9%1.8 $59.62
10/29/202122,400,000 shares $1.31 billion +7.5%1.0%2.2 $58.40
Alien rocks potentially worth trillions… (Ad)

It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 trillion. These rare elements can’t be found on land… only in one high-pressure zone so extreme it could crush a human instantly. Inside? Materials essential to AI, quantum computing, and advanced weapons tech. That’s why global superpowers are in a race to secure them—and why Trump just signed an Executive Order pushing for immediate extraction.

Get the name and ticker of the $7 stock leading America’s supply race.
10/15/202120,830,000 shares $1.22 billion +4.6%0.9%2.2 $58.36
9/30/202119,910,000 shares $1.18 billion -5.2%0.9%2.2 $59.17
9/15/202120,990,000 shares $1.30 billion +3.3%1.0%2.4 $62.00
8/31/202120,320,000 shares $1.36 billion +5.1%0.9%2.4 $66.86
8/13/202119,340,000 shares $1.31 billion -11.7%0.9%2.2 $67.51
7/30/202121,910,000 shares $1.49 billion +13.1%1.0%2.4 $67.87
7/15/202119,380,000 shares $1.31 billion +19.8%N/A2 $67.43
6/30/202116,180,000 shares $1.08 billion -22.2%N/A1.6 $66.82
6/15/202120,790,000 shares $1.40 billion +24.0%N/A2 $67.42
5/28/202116,770,000 shares $1.10 billion +4.9%N/A1.6 $65.72
5/14/202115,990,000 shares $1.04 billion -23.8%N/A1.4 $65.04
4/30/202120,970,000 shares $1.32 billion +10.5%N/A1.7 $62.89
4/15/202118,980,000 shares $1.21 billion +12.6%N/A1.5 $63.81
3/31/202116,860,000 shares $1.07 billion -33.0%N/A1.3 $63.31
3/15/202125,160,000 shares $1.53 billion -10.8%N/A2 $60.64
2/26/202128,190,000 shares $1.75 billion +35.6%N/A2.3 $62.10
2/12/202120,790,000 shares $1.25 billion +6.8%N/A1.8 $59.99
1/29/202119,470,000 shares $1.21 billion -1.3%N/A1.7 $62.29
1/15/202119,730,000 shares $1.30 billion +31.4%N/A1.8 $66.02
12/31/202015,020,000 shares $930.04 million -2.5%N/A1.4 $61.92
12/15/202015,410,000 shares $924.14 million +0.7%N/A1.5 $59.97
11/30/202015,300,000 shares $964.67 million -5.2%N/A1.5 $63.05
11/15/202016,140,000 shares $1.03 billion +2.7%N/A1.5 $63.62
10/30/202015,710,000 shares $909.92 million +14.3%N/A1.5 $57.92
10/15/202013,750,000 shares $1.49 billion +18.3%N/A1.4 $108.24
9/30/202011,620,000 shares $1.26 billion -19.1%N/A1.2 $108.24
9/15/202014,360,000 shares $1.55 billion -3.4%N/A1.4 $108.24
8/31/202014,860,000 shares $1.61 billion +2.8%N/A1.3 $108.24
8/14/202014,450,000 shares $1.56 billion -30.2%N/A1.1 $108.24

BMY Short Interest - Frequently Asked Questions

What is Bristol Myers Squibb's current short interest?

Short interest is the volume of Bristol Myers Squibb shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 38,380,000 shares of BMY short. 1.89% of Bristol Myers Squibb's shares are currently sold short. Learn More on Bristol Myers Squibb's current short interest.

What is a good short interest ratio for Bristol Myers Squibb?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMY shares currently have a short interest ratio of 3.0. Learn More on Bristol Myers Squibb's short interest ratio.

Which institutional investors are shorting Bristol Myers Squibb?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol Myers Squibb: Allianz Asset Management GmbH, Twin Tree Management LP, Total Wealth Planning & Management Inc., CenterStar Asset Management LLC, Quaker Wealth Management LLC, Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, CMT Capital Markets Trading GmbH, Cubist Systematic Strategies LLC, Caption Management LLC, Nomura Holdings Inc., Susquehanna International Group LLP, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Garda Capital Partners LP, Credit Agricole S A, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, Citigroup Inc., Delta Accumulation LLC, Arkadios Wealth Advisors, LPL Financial LLC, Readystate Asset Management LP, and Allianz Asset Management GmbH. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Bristol Myers Squibb?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.89% of Bristol Myers Squibb's floating shares are currently sold short.

Is Bristol Myers Squibb's short interest increasing or decreasing?

Bristol Myers Squibb saw a decrease in short interest in July. As of July 15th, there was short interest totaling 38,380,000 shares, a decrease of 2.7% from the previous total of 39,450,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bristol Myers Squibb's float size?

Bristol Myers Squibb currently has issued a total of 2,035,081,000 shares. Some of Bristol Myers Squibb's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bristol Myers Squibb currently has a public float of 2,030,000,000 shares.

How does Bristol Myers Squibb's short interest compare to its competitors?

1.89% of Bristol Myers Squibb's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Bristol Myers Squibb: Amgen Inc. (2.74%), Exelixis, Inc. (6.92%), Gilead Sciences, Inc. (1.82%), Moderna, Inc. (19.34%), Vertex Pharmaceuticals Incorporated (1.64%), AbbVie Inc. (0.89%), Johnson & Johnson (0.76%), Eli Lilly and Company (0.90%), Merck & Co., Inc. (1.15%), Pfizer Inc. (1.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Bristol Myers Squibb stock?

Short selling BMY is an investing strategy that aims to generate trading profit from Bristol Myers Squibb as its price is falling. BMY shares are trading up $0.94 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bristol Myers Squibb?

A short squeeze for Bristol Myers Squibb occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMY, which in turn drives the price of the stock up even further.

How often is Bristol Myers Squibb's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMY, twice per month. The most recent reporting period available is July, 15 2025.



Related Companies
Short Interest Tools

This page (NYSE:BMY) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners
Microsoft's Next Big Bet?
Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...
Stansberry Research | Sponsored
I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...
Timothy Sykes | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...
Brownstone Research | Sponsored
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored
Alien rocks potentially worth trillions…
It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...
Porter & Company | Sponsored